SuperGen to Present at UBS Global Life Sciences Conference

DUBLIN, Calif., Sept. 21 /PRNewswire-FirstCall/ -- SuperGen Inc. (NASDAQ:SUPG) today announced that James S. Manuso, Ph.D., President and Chief Executive Officer is scheduled to present at the UBS Global Life Sciences Conference, at 8:00 a.m. EDT on Sept. 28, 2006, at the Grand Hyatt Hotel in New York City. Dr. Manuso will provide a brief corporate overview and discuss the Company's recent progress.

A live Webcast of Dr. Manuso's presentation will be available on the Investor Relations section of the Company's website at www.supergen.com. The Webcast will be archived for 90 days.

About SuperGen

Based in Dublin, Calif., SuperGen is a pharmaceutical company dedicated to the discovery, acquisition, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on inhibitors of aurora-A, tyrosine kinase and DNA methyltransferase. For more information about SuperGen, please visit http://www.supergen.com.

    Contacts:

    SuperGen
    Timothy L. Enns
    S.V.P., Corporate Communications & Business Development
    (925) 560-0100 x111
    tenns@supergen.com

    Noonan Russo
    Sharon Weinstein, (212) 845-4271 (Investors)
    sharon.weinstein@eurorscg.com

    Tracey Milani, (858) 546-4811 (Media)
    tracey.milani@eurorscg.com

Source: SuperGen Inc.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here